OTCPK:GTVI

Stock Analysis Report

Joway Health Industries Group

Executive Summary

Joway Health Industries Group Inc., through its subsidiaries, manufactures, distributes, and sells tourmaline-related healthcare products.


Snowflake Analysis

Overvalued with worrying balance sheet.

Share Price & News

How has Joway Health Industries Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GTVI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

GTVI

21.8%

US Consumer Durables

9.4%

US Market


1 Year Return

n/a

GTVI

-18.9%

US Consumer Durables

-6.8%

US Market

Return vs Industry: Insufficient data to determine how GTVI performed against the US Consumer Durables industry.

Return vs Market: Insufficient data to determine how GTVI performed against the US Market.


Shareholder returns

GTVIIndustryMarket
7 Day0%21.8%9.4%
30 Day-36.7%-21.0%-3.9%
90 Day35.1%-30.3%-16.5%
1 Yearn/a-17.7%-18.9%-4.8%-6.8%
3 Year-50.0%-50.0%-15.5%-19.4%23.4%15.2%
5 Year-16.7%-16.7%-9.5%-15.6%41.3%25.7%

Price Volatility Vs. Market

How volatile is Joway Health Industries Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

2 years ago | Simply Wall St

Best OTCPK Undervalued Stocks

2 years ago | Simply Wall St

Best OTCPK Undervalued Stocks

Valuation

Is Joway Health Industries Group undervalued compared to its fair value and its price relative to the market?

0.34x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate GTVI's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate GTVI's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: GTVI is unprofitable, so we can't compare its PE Ratio to the Consumer Durables industry average.

PE vs Market: GTVI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GTVI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GTVI is good value based on its PB Ratio (0.3x) compared to the US Consumer Durables industry average (0.8x).


Next Steps

Future Growth

How is Joway Health Industries Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

6.8%

Forecasted Consumer Durables industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Joway Health Industries Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of GTVI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Joway Health Industries Group's filings and announcements here.
  • Explore growth companies in the Consumer Durables industry.

Past Performance

How has Joway Health Industries Group performed over the past 5 years?

-17.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GTVI is currently unprofitable.

Growing Profit Margin: GTVI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: GTVI is unprofitable, and losses have increased over the past 5 years at a rate of -17.4% per year.

Accelerating Growth: Unable to compare GTVI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GTVI is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Durables industry (10%).


Return on Equity

High ROE: GTVI has a negative Return on Equity (-41.85%), as it is currently unprofitable.


Next Steps

Financial Health

How is Joway Health Industries Group's financial position?


Financial Position Analysis

Short Term Liabilities: GTVI's short term assets ($782.8K) do not cover its short term liabilities ($1.7M).

Long Term Liabilities: GTVI has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: GTVI's debt to equity ratio (50.1%) is considered high.

Reducing Debt: GTVI's debt to equity ratio has increased from 0.6% to 50.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GTVI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: GTVI has less than a year of cash runway if free cash flow continues to reduce at historical rates of -17.6% each year


Next Steps

Dividend

What is Joway Health Industries Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GTVI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate GTVI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GTVI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GTVI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GTVI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

US$33k

CEO Compensation


CEO

Jinghe Zhang (54yo)

9.58s

Tenure

US$32,655

Compensation

Mr. Jinghe Zhang is the Founder of Tianjin Joway Shengshi Group Co, Ltd. and has been its Chairman and Chief Executive Officer since 2007. Mr. Zhang has been Chief Executive Officer and President of Joway  ...


CEO Compensation Analysis

Compensation vs Market: Jinghe's total compensation ($USD32.66K) is below average for companies of similar size in the US market ($USD615.59K).

Compensation vs Earnings: Jinghe's compensation has been consistent with company performance over the past year.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Joway Health Industries Group Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Joway Health Industries Group Inc.
  • Ticker: GTVI
  • Exchange: OTCPK
  • Founded: 2003
  • Industry: Home Furnishings
  • Sector: Consumer Durables
  • Market Cap: US$1.003m
  • Shares outstanding: 20.05m
  • Website: https://www.jowayhealth.com

Number of Employees


Location

  • Joway Health Industries Group Inc.
  • No. 19, Baowang Road
  • Baodi Economic Development Zone
  • Tianjin
  • Tianjin Province
  • 301800
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GTVIOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 2010

Biography

Joway Health Industries Group Inc., through its subsidiaries, manufactures, distributes, and sells tourmaline-related healthcare products. The company operates in three segments: Healthcare Knit Goods, Daily Healthcare and Personal Care Products, and Wellness House and Activated Water Machine Products. It offers healthcare knit goods, including tourmaline treated mattresses, bed linen, underwear, pillows, and shirts; daily healthcare and personal care products, such as tourmaline-treated waist protectors, knee protectors, scarves, shampoo and soap products, toothpaste, and fish oil soft gel; and wellness house and activated water machine products comprising tourmaline wellness houses, foot sauna buckets, and tourmaline activated water machines and drinking mugs. The company markets and sells its products through a network of franchise stores. As of December 31, 2018, it had approximately 102 franchise stores. The company was formerly known as G2 Ventures, Inc. The company was founded in 2003 and is based in Tianjin, the People’s Republic of China. Joway Health Industries Group Inc. is a subsidiary of Crystal Globe Limited. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/09 03:54
End of Day Share Price2020/04/06 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.